Literature DB >> 15756656

Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis.

Ashesh B Jani1, Johnny Kao.   

Abstract

BACKGROUND: Radiotherapy (RT) has been used with success after radical retropubic prostatectomy (RRP), both in the adjuvant and salvage settings. The purpose of the current investigation was to systematically compare adjuvant versus salvage RT in a manner that incorporates both treatment efficacy and complications.
METHODS: A literature review was performed of reports of post-RRP salvage and adjuvant RT, and 12 trials comprising 1060 patients met the appropriate inclusion criteria. The biochemical failure-free survival in each study/arm was tabulated, and these values were entered into a model to compute an unadjusted number-needed-to treat (NNT). RT complications were then considered, accounting for differences in toxicity incidences in the salvage versus adjuvant setting, to compute complication-adjusted NNTs. In all the trials, the signs and magnitudes of the NNTs obtained were used to compare adjuvant with salvage RT.
RESULTS: The absolute NNT analysis showed an advantage of adjuvant compared with salvage RT. After adjustment for RT complications, however, the advantage shifted to salvage RT. This transition point from superiority of adjuvant RT to superiority of salvage RT was sensitive to the estimated incidence and severity of RT side effects.
CONCLUSIONS: Adjuvant post-RRP RT was advantageous in comparison to salvage RT if the side effects of RT were estimated to be negligible. However, with moderate incidence/severity of RT side effects, salvage RT was advantageous. The findings herein must be tested in a prospective study in which both health-related quality of life and cancer control are documented in patients receiving adjuvant versus salvage post-RRP RT. Further work is needed to better estimate parameters entered into the model to determine the precise transition point between adjuvant and salvage RT with modern RT techniques. (c) 2005 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756656     DOI: 10.1002/cncr.20949

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1. 

Authors:  Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

2.  Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.

Authors:  Ashesh B Jani; Eduard Schreibmann; Peter J Rossi; Joseph Shelton; Karen Godette; Peter Nieh; Viraj A Master; Omer Kucuk; Mark Goodman; Raghuveer Halkar; Sherrie Cooper; Zhengjia Chen; David M Schuster
Journal:  J Nucl Med       Date:  2016-09-08       Impact factor: 10.057

3.  Long-term complications in men who have early or late radiotherapy after radical prostatectomy.

Authors:  Robert J Sowerby; Johan Gani; Harold Yim; Sidney B Radomski; Charles Catton
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 4.  The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.

Authors:  Ashesh B Jani; Stanley L Liauw; Michael J Blend
Journal:  Clin Med Res       Date:  2007-06

5.  Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center.

Authors:  Olivier Riou; Pascal Fenoglietto; Benoit Laliberté; Cathy Menkarios; Carmen Llacer Moscardo; Meng Huor Hay; Norbert Ailleres; Jean-Bernard Dubois; Xavier Rebillard; David Azria
Journal:  ISRN Urol       Date:  2012-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.